4//SEC Filing
Genkin Dmitry 4
Accession 0001683168-19-002304
CIK 0001534525other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 6:50 PM ET
Size
11.9 KB
Accession
0001683168-19-002304
Insider Transaction Report
Form 4
Genkin Dmitry
Director
Transactions
- Award
Common Stock
2019-07-19+93,390→ 93,603 total
Footnotes (1)
- [F1]Shares acquired in connection the closing of the transaction contemplated by that certain Share Purchase agreement, dated March 1, 2019, with Hesperix SA, a Swiss corporation ("Hesperix"), the owners of Hesperix (each, a "Seller" and collectively, the "Sellers"), and Alexey Andreevich Vinogradov, as the representative of each Seller. The Reporting Person was a Seller in the transaction. On the closing date, the closing price of the Issuer's common stock was $4.85.
Documents
Issuer
Xenetic Biosciences, Inc.
CIK 0001534525
Entity typeother
Related Parties
1- filerCIK 0001711592
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 6:50 PM ET
- Size
- 11.9 KB